Related Experiment Video

Updated: Nov 17, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.8K

Treatable Mechanisms in Asthma

Mario Cazzola1, Josuel Ora2, Francesco Cavalli2

  • 1Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy. mario.cazzola@uniroma2.it.

Molecular Diagnosis & Therapy
|February 11, 2021
PubMed

Insights

Personalizing asthma treatment remains challenging due to its complex nature. Research is advancing to identify specific asthma phenotypes and endotypes, or "treatable traits," for more targeted and effective therapies.

Area of Science:

  • Pulmonology
  • Genetics
  • Precision Medicine

Background:

  • Asthma is a complex, heterogeneous respiratory disease with a lack of targeted treatment strategies.
  • Current approaches to classifying asthma into pheno-/endotypes for personalized therapy face significant identification and validation challenges.

Purpose of the Study:

  • To explore advanced strategies for personalizing asthma management.
  • To address the limitations in identifying and validating asthma phenotypes and endotypes.
  • To investigate the potential of precision medicine approaches beyond traditional diagnostic labels.

Main Methods:

  • Review of current challenges in asthma phenotyping and endotyping.
  • Discussion of precision medicine strategies focusing on "treatable traits" in airway diseases.
  • Highlighting the role of '-omic' sciences and big data in understanding molecular pathways.

Main Results:

  • Existing methods for asthma phenotyping and endotyping require further refinement for clinical application.
  • The concept of "treatable traits" is currently too imprecise due to a lack of mechanistic understanding.
  • Advancements in '-omic' data management are crucial for identifying molecular pathways to guide targeted asthma therapies.

Conclusions:

  • Personalized asthma treatment requires robust identification and validation of patient subgroups.
  • Precision medicine in asthma may benefit from focusing on underlying molecular mechanisms rather than broad "treatable traits."
  • Continued research integrating '-omic' data is essential for developing effective, individualized asthma management strategies.

More Related Videos

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

43.6K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

4.3K

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
963
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K